Sutro Biopharma, Inc.
STRO
$20.48
-$0.83-3.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -180.64M | -153.60M | -191.09M | -216.77M | -208.70M |
| Total Depreciation and Amortization | 6.06M | 6.70M | 7.32M | 7.57M | 7.47M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.79M | 53.49M | 56.93M | 57.48M | 34.95M |
| Change in Net Operating Assets | -21.39M | -58.20M | -50.40M | -70.81M | -82.58M |
| Cash from Operations | -145.17M | -151.61M | -177.23M | -222.53M | -248.86M |
| Capital Expenditure | -446.00K | -532.00K | -1.70M | -2.58M | -3.16M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.23M | 16.54M | 46.71M | 116.38M | 224.26M |
| Cash from Investing | 32.79M | 16.01M | 45.01M | 113.80M | 221.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 103.37M | 103.37M | 376.00K | 373.00K | 1.34M |
| Repurchase of Common Stock | -670.00K | -312.00K | -332.00K | -289.00K | -338.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 102.70M | 103.05M | 44.00K | 84.00K | 999.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.69M | -32.55M | -132.17M | -108.65M | -26.76M |